Search for SCA2 blood RNA biomarkers highlights Ataxin-2 as strong modifier of the mitochondrial factor PINK1 levels

Sen, Nesli; Drost, Jessica; Gispert, Suzana; Torres-Odio, Sylvia; Damrath, Ewa; Klinkenberg, Michael; Hamzeiy, Hamid; AKDAL HALMAGYI, GÜLDEN; Gulluoglu, Halil; Basak, A.; Auburger, Georg

doi:10.1016/j.nbd.2016.09.002

Search for SCA2 blood RNA biomarkers highlights Ataxin-2 as strong modifier of the mitochondrial factor PINK1 levels

Sen N. E., Drost J., Gispert S., Torres-Odio S., Damrath E., Klinkenberg M., ...More

NEUROBIOLOGY OF DISEASE, vol.96, pp.115-126, 2016 (SCI-Expanded, Scopus)

Publication Type: Article / Article
Volume: 96
Publication Date: 2016
Doi Number: 10.1016/j.nbd.2016.09.002
Journal Name: NEUROBIOLOGY OF DISEASE
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Page Numbers: pp.115-126
Keywords: Mitochondrial dynamics, Autophagy, Ribosomal translation, RNA processing, Parkinsonism, Neurodegeneration
Dokuz Eylül University Affiliated: Yes

Abstract

Ataxin-2 (ATXN2) polyglutamine domain expansions of large size result in an autosomal dominantly inherited multi-system-atrophy of the nervous system named spinocerebellar ataxia type 2 (SCA2), while expansions of intermediate size act as polygenic risk factors for motor neuron disease (ALS and FTLD) and perhaps also for Levodopa-responsive Parkinson's disease (PD).